Overview
Yihebali Chi practices in Beijing, China. Chi is rated as an Advanced expert by MediFind in the treatment of Hypophosphatemia. Their top areas of expertise are Medullary Thyroid Carcinoma, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Gastrectomy, and Pancreaticoduodenectomy.
Their clinical research consists of co-authoring 82 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Hypophosphatemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- HypophosphatemiaChi isAdvanced. Learn about Hypophosphatemia.
- Medullary Thyroid Carcinoma
- Neuroendocrine Tumor
- Pancreatic Islet Cell Tumor
- Thyroid CancerChi isAdvanced. Learn about Thyroid Cancer.
- Experienced
- Adult Soft Tissue SarcomaChi isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisChi isExperienced. Learn about Agranulocytosis.
- ArthritisChi isExperienced. Learn about Arthritis.
- Colorectal CancerChi isExperienced. Learn about Colorectal Cancer.
- DiarrheaChi isExperienced. Learn about Diarrhea.
- Disseminated Intravascular Coagulation